0001100682false00011006822024-05-082024-05-08


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K


CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


May 8, 2024
Date of Report (Date of earliest event reported)


CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
(Exact Name of Registrant as Specified in Charter)
Delaware001-1594306-1397316
(State or Other
Jurisdiction of Incorporation)		(Commission File Number)(IRS Employer
Identification No.)

251 Ballardvale Street
Wilmington, Massachusetts 01887
(Address of Principal Executive Offices) (Zip Code)

781-222-6000
(Registrant’s Telephone Number, including Area Code)

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, $0.01 par valueCRLNew York Stock Exchange
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 5.07 Submission of Matters to a Vote of Security Holders

Charles River Laboratories International, Inc. (the "Company") held its Annual Meeting of Shareholders on May 8, 2024. For more information on the following proposals, see the Company’s proxy statement dated March 29, 2024. At the Company’s Annual Meeting, the following proposals were adopted by the votes specified below:

(a) The following eleven (11) directors were elected to serve until our 2025 Annual Meeting of Shareholders and received the number of votes listed opposite each of their names below:
Number of Shares Voted ForNumber of Shares Voted AgainstNumber of Shares AbstainedBroker Non-Votes
James C. Foster43,667,2812,380,275140,6442,038,517
Nancy C. Andrews45,474,179688,93125,0902,038,517
Robert J. Bertolini44,599,8611,562,94025,3992,038,517
Reshema Kemps-Polanco46,096,09466,86525,2412,038,517
Deborah T. Kochevar43,252,3032,910,57825,3192,038,517
George Llado, Sr.45,449,038713,92925,2332,038,517
Martin W. Mackay39,753,3646,409,76525,0712,038,517
George E. Massaro43,532,4732,629,96725,7602,038,517
Craig B. Thompson46,041,753121,23325,2142,038,517
Richard F. Wallman44,122,0232,040,68025,4972,038,517
Virginia M. Wilson45,342,311820,48125,4082,038,517

(b) The shareholders approved, on an advisory, non-binding basis, the compensation of our named executive officers.
ForAgainstAbstainBroker Non-Votes
43,833,5032,299,36255,3352,038,517

(c) The shareholders approved the ratification of the appointment of PricewaterhouseCoopers LLP as our independent auditors for fiscal 2024.
ForAgainstAbstainBroker Non-Votes
45,612,8372,586,70427,1760

(e) The shareholders did not approve the shareholder proposal submitted by PETA to publish a report on non-human primates imported by the Company.

ForAgainstAbstainBroker Non-Votes
11,428,43234,538,572221,1962,038,517

Computershare Trust Company, N.A., our transfer agent, acted as independent proxy tabulator and Inspector of Election at the Annual Meeting of Shareholders.
2

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
 
Date:May 10, 2024By:/s/ Matthew L. Daniel
Matthew L. Daniel, Corporate Senior Vice President,
General Counsel, Corporate Secretary & Chief Compliance Officer

3
v3.24.1.1.u2
Cover Page
May 08, 2024
Cover [Abstract]  
Document Type 8-K
Document Period End Date May 08, 2024
Entity Registrant Name CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Entity Incorporation, State or Country Code DE
Entity File Number 001-15943
Entity Tax Identification Number 06-1397316
Entity Address, Address Line One 251 Ballardvale Street
Entity Address, City or Town Wilmington
Entity Address, State or Province MA
Entity Address, Postal Zip Code 01887
City Area Code 781
Local Phone Number 222-6000
Title of 12(b) Security Common stock, $0.01 par value
Trading Symbol CRL
Security Exchange Name NYSE
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Central Index Key 0001100682
Amendment Flag false
Charles River Laboratories (NYSE:CRL)
Gráfica de Acción Histórica
De Abr 2024 a May 2024 Haga Click aquí para más Gráficas Charles River Laboratories.
Charles River Laboratories (NYSE:CRL)
Gráfica de Acción Histórica
De May 2023 a May 2024 Haga Click aquí para más Gráficas Charles River Laboratories.